June 2009
Medical Device Daily;6/16/2009, Vol. 13 Issue 114, p4
This section offers news briefs on the medical device industry. A web site was launched by Perceptive Informatics designed to aid investigators in applying the 1.1 version of Responsive Evaluation Criteria in Solid Tumors (RECIST) in oncology trials. A notice was provided by Northstar Neuroscience to the Nasdaq Stock Market informing about its intention to voluntarily delist from the Nasdaq Global Market. VNUS Medical Technologies released estimates of the number of patients treated using its VNUS Closure radio frequency vein ablation system.


Related Articles

  • Date set for Diomed's request for injunction versus Total Vein.  // Medical Device Daily;1/16/2008, Vol. 12 Issue 11, p4 

    The article reveals the schedule set by the court to hear Diomed Holdings' request for a preliminary injunction against Total Vein Solutions in a patent dispute concerning the endovascular laser treatment of varicose veins. Diomed president James Wylie said they have been pleased with the...

  • Acquisitions & Agreements.  // Cardiovascular Devices & Drugs;Aug2009, Vol. 15 Issue 8, p17 

    This section offers news briefs that relate to acquisitions and agreements in the medical device industry. A subsidiary of healthcare products provider Covidien paid 440 million U.S. dollars to acquire VNUS Medical Technologies. Cardiovascular core laboratory Medifacts International has acquired...

  • Jury awards VNUS $46M in patent infringement case.  // Medical Device Daily;12/13/2010, Vol. 14 Issue 240, p3 

    The article reports on the 46 million U.S. dollars awarded to VNUS Medical Technologies in a patent infringement case involving Total Vein Solutions and Biolitec.

  • Northstar suspends its stroke work to place focus on depression. PEDERSEN, AMANDA // Cardiovascular Devices & Drugs;Sep2008, Vol. 14 Issue 9, p9 

    This section offers news on the stroke segment of the medical technology industry. Concentric Medical launched a new series of its Merci Retrievers in the U.S. that will provide physicians with additional options for restoring blood flow in patients who have suffered ischemic strokes. Northstar...

  • Med-Tech Notes.  // Medical Device Daily;5/2/2011, Vol. 15 Issue 84, p4 

    This section offers news briefs on medical technology. A website was launched by Latest Medical, which offers personalized information to cancer patients about new treatment innovations. A 10-year follow-up trial is being hosted by Heekin Orthopedic Specialists for the ConforMIS iUni G2 knee...

  • VNUS MEDICAL REPORTS $1 MILLION 3RD QTR '04 NET INCOME.  // Biotech Financial Reports;Jan2005, p7 

    The article informs that VNUS Medical Technologies, Inc., San Jose, California, a provider of medical devices for the minimally invasive treatment of venous reflux disease, has announced its financial results for the third quarter ended September 30, 2004. The company completed its initial...

  • VNUS LAUNCHES "CLOSURE PLUS" CATHETER FOR VENOUS REFLUX.  // Biotech Equipment Update;Nov2003, p2 

    VNUS Medical Technologies in San Jose, California has introduced a new radio frequency delivery device, Closure PLUS, for the treatment of saphenous vein reflux, often an underlying cause of varicose veins. The Closure System has previously been shown in multiple randomized trials to offer...

  • VNUS CLOSUREFAST CATHETER CLINICAL TRIAL HAS GOOD RESULTS.  // Biotech Equipment Update;Apr2007, Vol. 15 Issue 4, p7 

    The article reports that Professor and Dr. Thomas Proebstle of the University of Heidelberg, Germany, presented the clinical trial report of ClosureFAST endovenous radiofrequency vein ablation catheter at the American Venous Forum meeting in San Diego, California. ClosureFast is designed and...

  • VNUS says 'significant' new patent allowed by U.S. PTO.  // Medical Device Daily;4/21/2008, Vol. 12 Issue 77, p4 

    The article reports on the announcement by VNUS Medical Technologies, a maker of medical devices, that it has received a notice of allowability by the U.S. Patent & Trademark Office for a patent application that is continuation of one of the three patents in the VNUS patent infringement lawsuit...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics